- Home
- TMDX vs OPCH Comparison
TMDX vs OPCH Comparison
Compare TMDX & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- OPCH
- Stock Information
- Founded
- TMDX 1998
- OPCH N/A
- Country
- TMDX United States
- OPCH United States
- Employees
- TMDX N/A
- OPCH N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OPCH Medical/Nursing Services
- Sector
- TMDX Health Care
- OPCH Health Care
- Exchange
- TMDX Nasdaq
- OPCH Nasdaq
- Market Cap
- TMDX 4.7B
- OPCH 5.0B
- IPO Year
- TMDX 2019
- OPCH N/A
- Fundamental
- Price
- TMDX $84.84
- OPCH $22.11
- Analyst Decision
- TMDX Buy
- OPCH Buy
- Analyst Count
- TMDX 10
- OPCH 5
- Target Price
- TMDX $138.20
- OPCH $31.20
- AVG Volume (30 Days)
- TMDX 2.2M
- OPCH 2.6M
- Earning Date
- TMDX 10-28-2024
- OPCH 10-30-2024
- Dividend Yield
- TMDX N/A
- OPCH N/A
- EPS Growth
- TMDX N/A
- OPCH N/A
- EPS
- TMDX 0.94
- OPCH 1.19
- Revenue
- TMDX $401,090,000.00
- OPCH $4,776,174,000.00
- Revenue This Year
- TMDX $83.25
- OPCH $16.68
- Revenue Next Year
- TMDX $26.27
- OPCH $6.43
- P/E Ratio
- TMDX $94.29
- OPCH $18.66
- Revenue Growth
- TMDX 109.09
- OPCH 13.58
- 52 Week Low
- TMDX $63.86
- OPCH $22.04
- 52 Week High
- TMDX $177.37
- OPCH $34.63
- Technical
- Relative Strength Index (RSI)
- TMDX 29.65
- OPCH 29.35
- Support Level
- TMDX $82.70
- OPCH $22.26
- Resistance Level
- TMDX $98.88
- OPCH $23.28
- Average True Range (ATR)
- TMDX 5.28
- OPCH 0.89
- MACD
- TMDX 1.28
- OPCH -0.15
- Stochastic Oscillator
- TMDX 26.03
- OPCH 1.98
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.